The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies
出版年份 2018 全文链接
标题
The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies
作者
关键词
-
出版物
Cancers
Volume 10, Issue 9, Pages 327
出版商
MDPI AG
发表日期
2018-09-13
DOI
10.3390/cancers10090327
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bavachin induces the apoptosis of multiple myeloma cell lines by inhibiting the activation of nuclear factor kappa B and signal transducer and activator of transcription 3
- (2018) Tomoya Takeda et al. BIOMEDICINE & PHARMACOTHERAPY
- Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
- (2018) Enrico Tiacci et al. BLOOD
- Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments
- (2018) Jingping Hu et al. CANCER LETTERS
- Mutations in the signal transducer and activator of transcription family of genes in cancer
- (2018) Nahid Shahmarvand et al. CANCER SCIENCE
- B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
- (2018) Xingli Zhao et al. MOLECULAR THERAPY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
- (2018) Jenny D. Beebe et al. PHARMACOLOGY & THERAPEUTICS
- Constitutive Phosphorylation of STAT3 by the CK2–BLNK–CD5 Complex
- (2017) Uri Rozovski et al. MOLECULAR CANCER RESEARCH
- Butein in health and disease: A comprehensive review
- (2017) Ganesan Padmavathi et al. PHYTOMEDICINE
- Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression
- (2016) Jinheng Wang et al. JOURNAL OF PATHOLOGY
- Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia
- (2016) Xianjun Yu et al. MOLECULES
- Importins and exportins as therapeutic targets in cancer
- (2016) Amit Mahipal et al. PHARMACOLOGY & THERAPEUTICS
- Targeting transcription factor STAT3 for cancer prevention and therapy
- (2016) Edna Zhi Pei Chai et al. PHARMACOLOGY & THERAPEUTICS
- Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin’s lymphoma
- (2016) Wei Ju et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantifying the dynamics of the oligomeric transcription factor STAT3 by pair correlation of molecular brightness
- (2016) Elizabeth Hinde et al. Nature Communications
- Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies
- (2015) Linda M. Scott et al. BLOOD REVIEWS
- A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- (2015) Naveen Pemmaraju et al. Clinical Lymphoma Myeloma & Leukemia
- Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer
- (2015) Matteo Santoni et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3
- (2015) Xiaoyun Dai et al. Molecular Oncology
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer
- (2015) Shrikant Balasaheb Mali ORAL ONCOLOGY
- Potential of butein, a tetrahydroxychalcone to obliterate cancer
- (2015) Ganesan Padmavathi et al. PHYTOMEDICINE
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells
- (2015) Laixi Bi et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Conjugate adaptive optics in widefield microscopy with an extended-source wavefront sensor
- (2015) Jiang Li et al. Optica
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
- (2014) Kodappully Sivaraman Siveen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells
- (2014) K S Siveen et al. BRITISH JOURNAL OF CANCER
- Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinomain Vitroandin Vivo
- (2014) Chakrabhavi Dhananjaya Mohan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex
- (2014) Qiao Zhang et al. Molecular Cancer
- STAT3 Inhibitors: Finding a Home in Lymphoma and Leukemia
- (2014) J. Munoz et al. ONCOLOGIST
- STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia
- (2014) Øystein Bruserud et al. Expert Review of Hematology
- Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
- (2014) Ailian Xiong et al. Cancers
- Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
- (2013) Aruljothi Subramaniam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth inHMGA1transgenic model of T-cell leukemia
- (2013) Joelle Hillion et al. LEUKEMIA & LYMPHOMA
- Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes
- (2012) Ivan H. W. Ng et al. BIOCHEMICAL JOURNAL
- Molecular insight in the multifunctional activities of Withaferin A
- (2012) Wim Vanden Berghe et al. BIOCHEMICAL PHARMACOLOGY
- Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia
- (2012) Chie Ishikawa et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Activation of Estrogen Receptor by Bavachin from Psoralea corylifolia
- (2012) Joon-Woo Park et al. Biomolecules & Therapeutics
- Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
- (2012) B. Will et al. BLOOD
- Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells
- (2012) L. Zhang et al. BLOOD
- Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo
- (2012) P. Rajendran et al. Cancer Prevention Research
- Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45
- (2012) Ryohei Wakahara et al. GENES TO CELLS
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-Hodgkin lymphoma
- (2012) Kate R Shankland et al. LANCET
- Novel players in multiple myeloma pathogenesis: Role of protein kinases CK2 and GSK3
- (2012) Francesco Piazza et al. LEUKEMIA RESEARCH
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of STAT3 in Transformation and Drug Resistance in CML
- (2012) Rajesh R. Nair et al. Frontiers in Oncology
- Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
- (2011) M. S. Redell et al. BLOOD
- Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
- (2011) Radhamani Kannaiyan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Non-Hodgkin's Lymphoma: The Old and the New
- (2011) Fernando Cabanillas Clinical Lymphoma Myeloma & Leukemia
- The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3
- (2011) M. Vogt et al. JOURNAL OF CELL SCIENCE
- Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway
- (2011) Wan Du et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- STAT3 SIGNALING: Anticancer Strategies and Challenges
- (2011) P. A. Johnston et al. MOLECULAR INTERVENTIONS
- TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
- (2010) Vijay Ramakrishnan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
- (2009) F. P. S. Santos et al. BLOOD
- Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562
- (2009) Kin Tak Chan et al. CANCER LETTERS
- Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
- (2009) Mustafa Benekli et al. JOURNAL OF CLINICAL ONCOLOGY
- Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo
- (2009) R. Burger et al. MOLECULAR CANCER THERAPEUTICS
- Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1
- (2008) K. S. Ahn et al. CANCER RESEARCH
- STAT3 as a target for inducing apoptosis in solid and hematological tumors
- (2008) Khandaker Al Zaid Siddiquee et al. CELL RESEARCH
- STAT 3 as a Target for Cancer Drug Discovery
- (2008) Luca Costantino et al. CURRENT MEDICINAL CHEMISTRY
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-κB and STAT3 pathways in Hodgkin's lymphoma cells
- (2008) Gerardo G. Mackenzie et al. INTERNATIONAL JOURNAL OF CANCER
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
- The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia
- (2008) Stefan Kasper et al. LEUKEMIA RESEARCH
- Butein Suppresses Constitutive and Inducible Signal Transducer and Activator of Transcription (STAT) 3 Activation and STAT3-Regulated Gene Products through the Induction of a Protein Tyrosine Phosphatase SHP-1
- (2008) M. K. Pandey et al. MOLECULAR PHARMACOLOGY
- The JAK kinases: Not just another kinase drug discovery target
- (2008) Andrew F. Wilks SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- SOCS regulation of the JAK/STAT signalling pathway
- (2008) Ben A. Croker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now